Aspen API response to COVID-19
Latest update / 1 September 2021
Login
Healthcare. We Care.
Group sites
Development
Solutions
Contract development & manufacturing
Process development & optimization
Technology platform
Manufacturing capabilities
Analytical development
Project management
Established
API Portfolio
High potency & oncology APIs
Peptides
Narcotics & analgesic APIs
Botanical extraction APIs
Biochemical APIs
APIs under development
Service &
Support
Our sales team
Our regulatory support team
API
Catalogue
Our
Company
Our Brand
Our Quality & Regulatory
Our Sustainability
Our Network
Our People
Careers
Working for Aspen API
News
Contact
Sales
Support
Our locations
Aspen Oss
Menu
Aspen API.
Our commitment to sustainability in Pharma
Home
>
Aspen Oss News
Our commitment to sustainability in Pharma
Aspen Oss’ response to COVID-19
Successful GMP inspection by the Dutch Health Authorities
Upgrading and expansion of HCG API manufacturing completed
Successful ANVISA inspection on Heparin Sodium
Aspen Oss now ISO14001 and OHSAS 18001 certified
EDQM had granted a CEP for Leuprorelin
Successful GMP inspection for Aspen Oss
FDA successfully inspects Aspen Oss
EDQM granted CEP for tibolone
New GMP certificate Diosite and Moleneind
Successful GMP inspection diosite Moleneind
1
2
This website uses cookies to help us improve your user experience. By using the website, you consent to the use of these cookies.
Ok
All sites
Africa Middle East
Americas
Asia
Australasia
Europe CIS
Australia
Austria
Brazil
Canada
China
Czech Republic
France
Germany
France-NDB
Ghana-Kama
Japan
Kenya-Beta Healthcare
Malaysia
Mauritius
Menat
Mexico
New Zealand
Netherlands
Netherlands-Aspen API
Netherlands Oss
Nigeria
Philippines
Russia
Slovakia
South-Africa Ethicare
South-Africa FCC
South-Africa Holdings
South-Africa Nutritionals
South-Africa Pharmacare
Spain
Switzerland
Taiwan
Tanzania-Shelys
USA
